Amarex Clinic Research is a contract research organization in Germantown, Md. It will continue to operate out of its U.S. headquarters under the name Amarex Clinical Research, an NSF International company.
The majority interest acquisition will support NSF International’s health science services with expanded consulting services to the medical device industries.
“NSF International plays an important role in the pharmaceutical and biotech industry as a champion of quality, scientific rigor and best practices aimed at protecting and improving human health. Together with Amarex, we are creating a single source for integrated, expert health science consulting serves across the entire product lifecycle,” NSF International president and CEO Kevan Lawlor said in a news release. “Amarex brings clinical trial expertise to NSF International’s large base of training, quality and consulting clients, and Amarex’s CRO clients may now benefit from NSF International’s global reach and expertise in European Union Qualified Person and Medical Device Regulation training, chemistry manufacturing and controls support and supplement testing inspection and certification.”
Amarex will also support NSF International with regulatory affairs, project/trial management, clinical operations, biostatistics, data management, pharmacovigilance, data monitoring committees, medical writing and consulting.
“Amarex is excited to join the NSF International family. Amarex will be able to leverage NSF International’s global infrastructure to expand our contract research capabilities and better serve clients with the design and execution of clinical trials and navigating the FDA, TFDA and EMA regulatory approval process,” Amarex founder Kazem Kazempour said. “NSK International’s operational excellence will accelerate our expert team’s leap forward in the CRO market, and better help pharmaceutical, biotech and medical device/diagnostic companies develop products and services that will protect and improve human health while minimizing inefficiencies to save time and reduce unnecessary costs.”